On Friday, Predictive Oncology Inc (NASDAQ: POAI) opened higher 9.46% from the last session, before settling in for the closing price of $1.48. Price fluctuations for POAI have ranged from $0.55 to $3.76 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 6.59% annually for the last half of the decade. Company’s average yearly earnings per share was noted 40.23% at the time writing. With a float of $6.56 million, this company’s outstanding shares have now reached $6.67 million.
In an organization with 34 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 7.89%, operating margin of -958.27%, and the pretax margin is -954.17%.
Predictive Oncology Inc (POAI) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Medical Instruments & Supplies industry is another important factor to consider. The insider ownership of Predictive Oncology Inc is 1.59%, while institutional ownership is 3.61%.
Predictive Oncology Inc (POAI) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 40.23% per share during the next fiscal year.
Predictive Oncology Inc (NASDAQ: POAI) Trading Performance Indicators
Check out the current performance indicators for Predictive Oncology Inc (POAI). In the past quarter, the stock posted a quick ratio of 1.06. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.83.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.06, a number that is poised to hit -0.25 in the next quarter and is forecasted to reach -0.13 in one year’s time.
Technical Analysis of Predictive Oncology Inc (POAI)
Let’s dig in a bit further. During the last 5-days, its volume was 0.21 million. That was inferior than the volume of 4.01 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 64.03%. Additionally, its Average True Range was 0.18.
During the past 100 days, Predictive Oncology Inc’s (POAI) raw stochastic average was set at 42.63%, which indicates a significant decrease from 93.55% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 73.88% in the past 14 days, which was lower than the 134.61% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.1601, while its 200-day Moving Average is $1.0722. However, in the short run, Predictive Oncology Inc’s stock first resistance to watch stands at $1.6700. Second resistance stands at $1.7200. The third major resistance level sits at $1.8200. If the price goes on to break the first support level at $1.5200, it is likely to go to the next support level at $1.4200. The third support level lies at $1.3700 if the price breaches the second support level.
Predictive Oncology Inc (NASDAQ: POAI) Key Stats
There are currently 6,667K shares outstanding in the company with a market cap of 10.81 million. Presently, the company’s annual sales total 1,780 K according to its annual income of -13,980 K. Last quarter, the company’s sales amounted to 350 K and its income totaled -3,090 K.
